#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oropharyngeal cancer recurrent Infantile apnoea Anti-myelin-associated glycoprotein associated polyneuropathy T-cell lymphoma Congenital cystic kidney disease Optic glioma Muscular dystrophy Thymic carcinoma Follicular lymphoma stage I Small intestine adenocarcinoma Gaucher's disease type III Choroidal dystrophy Hyperinsulinism Philadelphia positive acute lymphocytic leukaemia Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Osteosarcoma – Diagnostics Primary immunodeficiency syndrome – Diagnostics Behcet’s syndrome Cystic fibrosis lung – Basic Information Undifferentiated sarcoma – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Richter’s syndrome – Treatment Von Willebrand’s disease – Trials in Disease Alveolar rhabdomyosarcoma – Life with Disease MELAS syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    4-IODOPHENYLALANINE I-131 Tafluprost Dronedarone Triglycerides, Medium Chain MARALIXIBAT Trazodone Rozanolixizumab GRAPHITE Edg-5506 Zolbetuximab Staphylococcus Aureus Nvdx3 Aticaprant Glimepiride Crisantaspase Patiromer Vincristine Sulfate Abc-23B-116 Linaclotide Danazol More therapies…

    Learn about Your Condition

    Somatic symptom disorder Intracranial calcification Optic atrophy Leiomyosarcoma Malignant melanoma Rectal cancer Intestinal obstruction Endocrine ophthalmopathy Ischaemic skin ulcer Pericarditis Vulval cancer recurrent Tympanic membrane hyperaemia Alagille syndrome Small cell lung cancer Paedophilia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Glofitamab
    France
  • Study on the Safety of GRWD5769 Alone and with Cemiplimab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Grwd5769
    • Cemiplimab
    France Spain
  • Study on How Abiraterone Affects Oxycodone in Men with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Oxycodone Hydrochloride
    The Netherlands
  • Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Ifosfamide
    • Dacarbazine
    Cyprus Czechia Denmark France Germany Italy +4
  • Study on Tocilizumab for Treating Acute Chest Syndrome in Children and Adults with Sickle Cell Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Sodium Chloride
    • Tocilizumab
    France
  • Study on Infection Prevention in Joint Replacement Surgery Using Povidone, Chlorhexidine, and Vancomycin for Adult Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzalkonium Chloride
    • Benzyl Alcohol
    • Chlorhexidine Gluconate
    Italy Spain
Previous Page
1 … 604 605 606 607 608 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!